ALERT!

This site is not optimized for Internet Explorer 8 (or older).

Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.

Aortic valve disease

June 19, 2024
Dr. Vince Gaudiani introduces his series on different techniques for aortic root reconstruction.
June 18, 2024
This video presents the case of a thirty-year-old woman who underwent a commando procedure to treat bacterial endocarditis.
June 14, 2024
This video demonstrates dissection of the visceral pericardium for ascending aortic and hemiarch replacement.
June 14, 2024
Prof. Tristan Yan demonstrates the importance of the visceral pericardium in addressing type A aortic dissection.
June 13, 2024
This paper reports the interim findings from the clinical registry that was initiated after FDA approval to validate the findings of the 386 PROACT trial for the On-X aortic valve. The original trial showed that low dose warfarin (INR range 1.5-2.0) and aspirin were safe starting at least three months after On-X aortic valve implantation.
June 5, 2024
In an analysis of 1,826 patients randomized to surgical aortic valve replacement in the three Placement of Aortic Transcatheter Valves (PARTNER) trials, patient-prosthesis mismatch was assessed using transthoracic echocardiography and by the normal reference value for each size and model of implanted valve.
June 5, 2024
Surgical explantation of transcatheter heart valves (THV) is rapidly increasing, but data on patients with THV-associated infective endocarditis (IE) is lacking. This study assessed the outcomes of patients undergoing THV explant for IE based on data from the international TAVR-EXPLANT Registry.
June 5, 2024
This video shows the case of a patient in Ghana who underwent a redo sternotomy and then a Bentall's operation for a dilated aortic root with severe regurgitation.
May 29, 2024
The DEDICATE-DZHK6 is a non-industry sponsored randomized noninferiority trial conducted at 38 sites in Germany, where patients with severe aortic stenosis who were at low or intermediate surgical risk were randomly assigned to undergo either transcatheter aortic valve implantation (TAVI) or surgical aortic valve replacement (SAVR).
May 29, 2024
In this recent paper, the authors set out to describe trends and outcomes for patients undergoing surgical aortic valve replacement in the Netherlands. They utilized the Netherlands Heart Registration database to analyze cases completed between 2007 and 2018.

Pages